These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2402800)

  • 1. Immunodeficiency after transplantation of alloantigen-matched bone marrow from an immunoregulatory mutant.
    Allen RD; Marshall JD; Roths JB; Sidman CL
    Transplantation; 1990 Sep; 50(3):516-8. PubMed ID: 2402800
    [No Abstract]   [Full Text] [Related]  

  • 2. Macrophage-derived complement component C4 can restore humoral immunity in C4-deficient mice.
    Gadjeva M; Verschoor A; Brockman MA; Jezak H; Shen LM; Knipe DM; Carroll MC
    J Immunol; 2002 Nov; 169(10):5489-95. PubMed ID: 12421924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What is graft versus host disease?
    van Bekkum DW
    Bone Marrow Transplant; 1991; 7 Suppl 2():110-1. PubMed ID: 1878668
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunodeficiency following human marrow transplantation: in vitro studies.
    Neely JE; Neely AN; Kersey JH
    Transplant Proc; 1978 Mar; 10(1):229-31. PubMed ID: 345562
    [No Abstract]   [Full Text] [Related]  

  • 5. Murine models of graft-versus-host disease with features of scleroderma.
    Charley MR; Deng JS
    Immunol Ser; 1989; 46():625-40. PubMed ID: 2488872
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunobiology of bone marrow transplantation: studies using scid mice.
    Murphy WJ; Kumar V; Bennett M
    Curr Top Microbiol Immunol; 1989; 152():251-8. PubMed ID: 2805793
    [No Abstract]   [Full Text] [Related]  

  • 7. [Factors influencing delayed type graft-versus-host disease after allogeneic bone marrow transplantation].
    Sueyoshi A
    Nihon Ketsueki Gakkai Zasshi; 1989 May; 52(3):630-8. PubMed ID: 2533445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunodeficiency and its complications of bone marrow transplantation from unrelated donors].
    Sao H
    Rinsho Ketsueki; 2000 Jun; 41(6):477-81. PubMed ID: 10921345
    [No Abstract]   [Full Text] [Related]  

  • 9. Haemopoietic stem cells and progenitors of functional T-lymphocytes in the bone marrow of 'nude' mice.
    Pritchard H; Micklem HS
    Clin Exp Immunol; 1973 Aug; 14(4):597-607. PubMed ID: 4583780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Recovery of immune function after bone marrow transplantation].
    Takagi S; Miura Y
    Rinsho Ketsueki; 1987 Mar; 28(3):323-30. PubMed ID: 3302350
    [No Abstract]   [Full Text] [Related]  

  • 11. Interferon alpha/beta synthesis during acute graft-versus-host disease.
    Reyes VE; Klimpel GR
    Transplantation; 1987 Mar; 43(3):412-6. PubMed ID: 3547798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The reconstitution of cellular immunity after bone marrow transplantation in children.
    Lanfranchi A; Porta F; Locatelli F; Zecca M; Nespoli L; Albertini A
    Haematologica; 1992; 77(4):336-47. PubMed ID: 1427444
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of p53 and Fas in a model of acute murine graft-versus-host disease.
    Yada S; Takamura N; Inagaki-Ohara K; O'leary MK; Wasem C; Brunner T; Green DR; Lin T; Pinkoski MJ
    J Immunol; 2005 Feb; 174(3):1291-7. PubMed ID: 15661885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow transplantation from mutant lpr/lpr mice. Functional abnormalities rather than alloantigenic differences appear to determine the development of a graft-vs.-host-like syndrome.
    Allen RD; Marshall JD; Roths JB; Sidman CL
    Eur J Immunol; 1990 Sep; 20(9):2057-66. PubMed ID: 2209703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rejection of bone marrow allografts by mice with severe combined immune deficiency (SCID). Evidence that natural killer cells can mediate the specificity of marrow graft rejection.
    Murphy WJ; Kumar V; Bennett M
    J Exp Med; 1987 Apr; 165(4):1212-7. PubMed ID: 3549961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunodeficiency associated with bone marrow transplantation.
    Ringdén O
    Curr Opin Immunol; 1989 Feb; 1(3):497-501. PubMed ID: 2553064
    [No Abstract]   [Full Text] [Related]  

  • 17. Bone marrow mesenchymal stem cells suppress lymphocyte proliferation in vitro but fail to prevent graft-versus-host disease in mice.
    Sudres M; Norol F; Trenado A; Grégoire S; Charlotte F; Levacher B; Lataillade JJ; Bourin P; Holy X; Vernant JP; Klatzmann D; Cohen JL
    J Immunol; 2006 Jun; 176(12):7761-7. PubMed ID: 16751424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of lethal graft-versus-host disease following allogeneic bone marrow transplantation in mice by short course administration of LF 08-0299.
    Annat J; Churaqui E; Dutartre P; Bruley-Rosset M
    Transplantation; 1996 Sep; 62(6):721-9. PubMed ID: 8824467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection.
    Jabado N; Le Deist F; Cant A; De Graeff-Meeders ER; Fasth A; Morgan G; Vellodi A; Hale G; Bujan W; Thomas C; Cavazzana-Calvo M; Wijdenes J; Fischer A
    Pediatrics; 1996 Sep; 98(3 Pt 1):420-8. PubMed ID: 8784367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study of the immunologic restoration of allogenic hematopoietic radiation chimeras].
    Hrsak I; Nouza K; Kolar V; Mathé G
    Rev Fr Etud Clin Biol; 1968 Nov; 13(9):887-93. PubMed ID: 4885128
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.